Regulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway*
- From the Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, S-171 77 Stockholm, Sweden
Abstract
HIF-1α (hypoxia-inducible factor 1α) is a basic-helix-loop-helix PAS (Per/Arnt/Sim) transcription factor that, under hypoxic conditions, dimerizes with a partner factor, the basic-helix-loop-helix/PAS protein Arnt, to recognize hypoxia-responsive elements of target genes. It has recently been demonstrated that HIF-1α protein but not mRNA levels are dramatically up-regulated in response to hypoxia. Here we show that inhibitors of 26 S proteasome activity produced a dramatic accumulation of endogenous as well as transfected HIF-1α protein under normoxic conditions, whereas the levels of Arnt protein were not affected. HIF-1α was polyubiquitinated in vivo under normoxic conditions, indicating rapid degradation via the ubiquitin-proteasome pathway. This degradation process appeared to target a region within the C terminus of HIF-1α. Importantly, HIF-1α ubiquitination was drastically decreased under hypoxic conditions. Up-regulation of HIF-1α protein by proteasome inhibitors did not result in transcriptional activation of reporter genes, indicating either the requirement of additional regulatory steps to induce functional activity of HIF-1α or the inability of polyubiquitinated forms of HIF-1α to mediate hypoxic signal transduction. In support of both these notions, we demonstrate that HIF-1α showed hypoxia-dependent translocation from the cytoplasm to the nucleus and that this regulatory mechanism was severely impaired in the presence of proteasome inhibitors. Taken together, these data demonstrate that the mechanism of hypoxia-dependent activation of HIF-1α is a complex multistep process and that stabilization of HIF-1α protein levels is not sufficient to generate a functional form.
Footnotes
-
↵* This work was supported by grants from the Swedish Cancer Society and the Swedish Medical Research Council.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵‡ Supported by a Marie Curie Research Training Grant from the European Commission.
-
↵§ Partly supported by the Uehara Memorial Foundation.
-
↵¶ To whom correspondence should be addressed. Tel.: +46-8-728 7330; Fax: +46-8-34 88 19; E-mail:lorenz.poellinger{at}cmb.ki.se.
-
↵2 P. Carrero, P. Coumailleau, S. O’Brien, and L. Poellinger, manuscript in preparation.
- Abbreviations:
- HIF-1α
-
hypoxia-inducible factor 1α
- EPAS1/HLF
-
endothelial PAS domain protein 1/HIF-1α-like factor
- PAS Per-Arnt-Sim homology
-
DotapN-[1(2, 3-dioleoyloxy)propyl]N,N,N-trimethylammonium methyl sulfate
- LLnL
-
N-acetyl-Leu-Leu-norleucinal
- CMV
-
cytomegalovirus
-
- Received May 12, 1998.
- Revision received December 9, 1998.
- The American Society for Biochemistry and Molecular Biology, Inc.
